ENTRY       D07984                      Drug
NAME        Fluvoxamine (INN)
FORMULA     C15H21F3N2O2
EXACT_MASS  318.1555
MOL_WEIGHT  318.3347
CLASS       Neuropsychiatric agent
             DG01659  Selective serotonin reuptake inhibitor (SSRI)
            Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
            Metabolizing enzyme inhibitor
             DG01634  CYP1A2 inhibitor
             DG01643  CYP2C9 inhibitor
             DG01933  CYP2C19 inhibitor
             DG01645  CYP2D6 inhibitor
             DG02852  CYP3A/CYP3A4 inhibitor
              DG01522  CYP3A4 inhibitor
REMARK      Same as: C07571
            ATC code: N06AB08
            Chemical structure group: DG00946
            Product (DG00946): D00824<JP/US>
EFFICACY    Antidepressant, Selective serotonin reuptake inhibitor (SSRI)
TARGET      SLC6A4 (HTT) [HSA:6532] [KO:K05037]
  PATHWAY   hsa04726(6532)  Serotonergic synapse
METABOLISM  Enzyme: CYP2D6 [HSA:1565]
INTERACTION CYP inhibition: CYP1A2 [HSA:1544], CYP2C19 [HSA:1557]; CYP2C9 [HSA:1559], CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]
STR_MAP     map07027  Antidepressants
            map07234  Neurotransmitter transporter inhibitors
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N06 PSYCHOANALEPTICS
               N06A ANTIDEPRESSANTS
                N06AB Selective serotonin reuptake inhibitors
                 N06AB08 Fluvoxamine
                  D07984  Fluvoxamine (INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01659  Selective serotonin reuptake inhibitor (SSRI)
               DG00946  Fluvoxamine
                D07984  Fluvoxamine
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00946  Fluvoxamine
                D07984  Fluvoxamine
             Metabolizing enzyme inhibitor
              DG01634  CYP1A2 inhibitor
               DG00946  Fluvoxamine
                D07984  Fluvoxamine
              DG01643  CYP2C9 inhibitor
               DG00946  Fluvoxamine
                D07984  Fluvoxamine
              DG01933  CYP2C19 inhibitor
               DG00946  Fluvoxamine
                D07984  Fluvoxamine
              DG01645  CYP2D6 inhibitor
               DG00946  Fluvoxamine
                D07984  Fluvoxamine
              DG02852  CYP3A/CYP3A4 inhibitor
               DG01522  CYP3A4 inhibitor
                DG00946  Fluvoxamine
                 D07984  Fluvoxamine
            Target-based classification of drugs [BR:br08310]
             Transporters
              Solute carrier family
               SLC6
                SLC6A4 (HTT)
                 D07984  Fluvoxamine (INN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D07984
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01659  Selective serotonin reuptake inhibitor (SSRI)
               DG00946  Fluvoxamine
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00946  Fluvoxamine
             Metabolizing enzyme inhibitor
              DG01634  CYP1A2 inhibitor
               DG00946  Fluvoxamine
              DG01643  CYP2C9 inhibitor
               DG00946  Fluvoxamine
              DG01933  CYP2C19 inhibitor
               DG00946  Fluvoxamine
              DG01645  CYP2D6 inhibitor
               DG00946  Fluvoxamine
              DG02852  CYP3A/CYP3A4 inhibitor
               DG01522  CYP3A4 inhibitor
                DG00946  Fluvoxamine
DBLINKS     CAS: 54739-18-3
            PubChem: 96024678
            ChEBI: 5138
            PDB-CCD: FVX
            LigandBox: D07984
            NIKKAJI: J11.936I
ATOM        22
            1   C8y C    19.9500  -16.8000
            2   C8x C    19.9500  -18.2000
            3   C8x C    21.1400  -18.9000
            4   C8y C    22.4000  -18.2000
            5   C8x C    22.4000  -16.8000
            6   C8x C    21.1400  -16.1000
            7   C1d C    18.7600  -16.1000
            8   X   F    17.5000  -15.4000
            9   X   F    19.3900  -14.8400
            10  X   F    18.1300  -17.3600
            11  C2c C    23.5900  -18.9000
            12  C1b C    24.8500  -18.2000
            13  N2b N    23.5900  -20.3000
            14  O2a O    24.8500  -21.0000
            15  C1b C    26.0400  -20.3000
            16  C1b C    27.2300  -21.0000
            17  N1a N    28.4200  -20.3000
            18  C1b C    25.9700  -18.9000
            19  C1b C    27.2300  -18.2000
            20  C1b C    28.4200  -18.9000
            21  O2a O    29.6100  -18.2000
            22  C1a C    30.8000  -18.9000
BOND        22
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     1   7 1
            8     7   8 1
            9     7   9 1
            10    7  10 1
            11    4  11 1
            12   11  12 1
            13   11  13 2
            14   13  14 1
            15   14  15 1
            16   15  16 1
            17   16  17 1
            18   12  18 1
            19   18  19 1
            20   19  20 1
            21   20  21 1
            22   21  22 1
///
